Less Ads, More Data, More Tools Register for FREE

Pin to quick pickshVIVO Share News (HVO)

Share Price Information for hVIVO (HVO)

Share Price is delayed by 15 minutes
Get Live Data
8.25    0.00 (0.00%)
Bid:
8.10
Ask:
8.60
Spread: 0.50 (6.173%)
Market Cap: £56.79m
HVO Live PriceLast checked at - London Stock Exchange

Intraday hVIVO Share Chart

hVIVO News

hVIVO secures GBP13.1 million contract for influenza B model
25 Jul 2023

hVIVO secures GBP13.1 million contract for influenza B model

(Alliance News) - hVIVO PLC on Tuesday said it has secured a GBP13.1 million contract with an unnamed pharmaceutical client to develop an influenza B ...

hVIVO inks deal to manufacture human hMPV virus for challenge trial
28 Jun 2023

hVIVO inks deal to manufacture human hMPV virus for challenge trial

(Alliance News) - hVIVO PLC on Wednesday said it has signed a deal to manufacture a human metapneumovirus virus and to conduct a characterisation stud...

IN THE KNOW: hVIVO involvement in drug approval should boost interest
2 Jun 2023

IN THE KNOW: hVIVO involvement in drug approval should boost interest

(Alliance News) - hVIVO's involvement in the approval of pharmaceutical giant Pfizer's new vaccine Abrysvo should support interest in its services, ac...

TRADING UPDATES: Skillcast swings to loss, RM Infrastructure NAV down
26 Apr 2023

TRADING UPDATES: Skillcast swings to loss, RM Infrastructure NAV down

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

EARNINGS SUMMARY: hVIVO sees 30% revenue growth; Next 15 lifts payout
25 Apr 2023

EARNINGS SUMMARY: hVIVO sees 30% revenue growth; Next 15 lifts payout

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Friday and not separately reported by Alliance News:

hVIVO touts positive test results from seasonal flu drug, CD388
3 Apr 2023

hVIVO touts positive test results from seasonal flu drug, CD388

(Alliance News) - hVIVO PLC on Monday said that Cidara Therapeutics Inc has seen positive results from an ongoing study testing CD388, a drug designed...

TRADING UPDATES: Inspirit Energy reports progress on Inspirit Charger
16 Mar 2023

TRADING UPDATES: Inspirit Energy reports progress on Inspirit Charger

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: